Private Sector and Partnering for Global Health

ADB, Manila May 30, 2012 William Lin, Ph.D. Johnson & Johnson

Disclaimer: The views expressed in this paper/presentation are the views of the author and do not necessarily reflect the views or policies of the Asian Development Bank (ADB), or its Board of Governors, or the governments they represent. ADB does not guarantee the accuracy of the data included in this paper and accepts no responsibility for any consequence of their use. Terminology used may not necessarily be consistent with ADB official terms.

Agenda
Johnson & Johnsons Philanthropy Partnering for NTDs

Neonatal Resuscitation Program

China

CONTRIBUTIONS

A Legacy of Caring
More than 100 years of giving, beginning with1906 San Francisco earthquake relief
Global disaster relief and philanthropy today 650 programs in more than 50 countries Focus on community-based partnerships to achieving impact >$600 million total giving in 2011

AIDS Orphan Salvation, China

3

Our Philanthropic Mission

Our primary focus is on making life- changing, long-term differences in human health by targeting the world's major health-related issues. We will fulfill this, and other philanthropic efforts, through community-based partnerships.

Our Strategic Pillars

Saving and improving the lives of women and children

Building the skills of people who serve community health needs, primarily through education

Preventing diseases and reducing stigma and disability in underserved communities in areas where Johnson & Johnson has a high potential for impact

Agenda
Johnson & Johnsons Philanthropy Partnering for NTDs

Holts Childrens Services

Korea

CONTRIBUTIONS

Commitment to MDGs Focusing on MCH

(September, 2010)

1. Mobile health for mothers

2. Safe childbirth 3. R&D innovations (HIV, TB, & NTDs) 4. Intestinal worms in children

Children Without Worms Partnership Priorities

Implementing partners to ensure capacity to deliver available medicines Education sector to include and deliver hygiene education WATSAN sector for sustaining improvements in health outcomes

Children Without Worms, Nicaragua

Partnering for Sustained Impact

Inclusion of hygiene education Helen Keller International, Cambodia

Improving water and sanitation World Wildlife Fund, Cameroon

Reaching non-enrolled Save the Children, Bangladesh

H3C O

O N HN O N H

Developing Flubendazole For oncho, LF, and loiasis

Flubendazole as a macrofilaricide can reduce time for eliminating onchocerciasis (river blindness) and lymphatic filariasis
Partnering with DNDi, Abbott, Michigan State University, McGill University and the Bill & Melinda Gates Foundation

Johnson & Johnson as Partner in Global Development

As a Pharma company we have to stick to our core competencies No single entity can do it alone We take a business approach to our philanthropy evidence-based approaches with M&E that includes robust impact indicators In line with ADBs Strategy 2020 for poverty reduction ADB recognizes that health is vital to development, productivity, social inclusion, and gender equity

11

In Support of What Matters

The biggest success of development has not been making people richer but, rather, has been making the things that really matter things like health and education cheaper and more widely available.
- Charles Kenny, 2012

12

Partners Coming Together Institutionalizing School-based Deworming for Poverty Reduction Salamat po

School-based deworming, Philippines

Hygiene education, Philippines

13